397 related articles for article (PubMed ID: 21744744)
1. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.
Ciotta L; Stracquadanio M; Pagano I; Carbonaro A; Palumbo M; Gulino F
Eur Rev Med Pharmacol Sci; 2011 May; 15(5):509-14. PubMed ID: 21744744
[TBL] [Abstract][Full Text] [Related]
2. [Effects of inositol on oocyte quality in patients affected with polycystic ovary syndrome].
Ciotta L; Stracquadanio M; Pagano I; Carbonaro A; Palumbo M; Gulino F
Minerva Ginecol; 2010 Dec; 62(6):525-31. PubMed ID: 21079574
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
Costantino D; Minozzi G; Minozzi E; Guaraldi C
Eur Rev Med Pharmacol Sci; 2009; 13(2):105-10. PubMed ID: 19499845
[TBL] [Abstract][Full Text] [Related]
4. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Papaleo E; Unfer V; Baillargeon JP; Fusi F; Occhi F; De Santis L
Fertil Steril; 2009 May; 91(5):1750-4. PubMed ID: 18462730
[TBL] [Abstract][Full Text] [Related]
5. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
Papaleo E; Unfer V; Baillargeon JP; De Santis L; Fusi F; Brigante C; Marelli G; Cino I; Redaelli A; Ferrari A
Gynecol Endocrinol; 2007 Dec; 23(12):700-3. PubMed ID: 17952759
[TBL] [Abstract][Full Text] [Related]
6. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
Regidor PA; Schindler AE; Lesoine B; Druckman R
Horm Mol Biol Clin Investig; 2018 Mar; 34(2):. PubMed ID: 29498933
[TBL] [Abstract][Full Text] [Related]
7. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.
Pacchiarotti A; Carlomagno G; Antonini G; Pacchiarotti A
Gynecol Endocrinol; 2016; 32(1):69-73. PubMed ID: 26507336
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A
Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
[TBL] [Abstract][Full Text] [Related]
9. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
Dinicola S; Chiu TT; Unfer V; Carlomagno G; Bizzarri M
J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908
[TBL] [Abstract][Full Text] [Related]
10. The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.
Morgante G; Orvieto R; Di Sabatino A; Musacchio MC; De Leo V
Fertil Steril; 2011 Jun; 95(8):2642-4. PubMed ID: 21300338
[TBL] [Abstract][Full Text] [Related]
11. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
Unfer V; Porcaro G
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
[TBL] [Abstract][Full Text] [Related]
12. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
Gerli S; Mignosa M; Di Renzo GC
Eur Rev Med Pharmacol Sci; 2003; 7(6):151-9. PubMed ID: 15206484
[TBL] [Abstract][Full Text] [Related]
13. The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.
Cittadini E
Fertil Steril; 2011 Jun; 95(8):e57; author reply e58. PubMed ID: 21514580
[No Abstract] [Full Text] [Related]
14. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Unfer V; Raffone E; Rizzo P; Buffo S
Gynecol Endocrinol; 2011 Nov; 27(11):857-61. PubMed ID: 21463230
[TBL] [Abstract][Full Text] [Related]
15. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.
Nordio M; Proietti E
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):575-81. PubMed ID: 22774396
[TBL] [Abstract][Full Text] [Related]
16. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.
Raffone E; Rizzo P; Benedetto V
Gynecol Endocrinol; 2010 Apr; 26(4):275-80. PubMed ID: 20222840
[TBL] [Abstract][Full Text] [Related]
17. Bye-bye chiro-inositol - myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction.
Galletta M; Grasso S; Vaiarelli A; Roseff SJ
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1212-4. PubMed ID: 22165685
[TBL] [Abstract][Full Text] [Related]
18. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Unfer V; Carlomagno G; Rizzo P; Raffone E; Roseff S
Eur Rev Med Pharmacol Sci; 2011 Apr; 15(4):452-7. PubMed ID: 21608442
[TBL] [Abstract][Full Text] [Related]
19. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study.
Rago R; Marcucci I; Leto G; Caponecchia L; Salacone P; Bonanni P; Fiori C; Sorrenti G; Sebastianelli A
J Biol Regul Homeost Agents; 2015; 29(4):913-23. PubMed ID: 26753656
[TBL] [Abstract][Full Text] [Related]
20. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Rizzo P; Raffone E; Benedetto V
Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):555-61. PubMed ID: 20712264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
